- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04399512
Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis Patients
Evaluation of Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Haryana
-
Rohtak, Haryana, India, 124001
- Recruiting
- Post Graduate Institute of Dental Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:(cirrhosis patients)
- Known patient of cirrhosis(Diagnosis of cirrhosis is based on blood testing, medical imaging, and liver biopsy.) with mature permanent teeth .
- Age35-55 years
- > or equal to 8 natural teeth(excluding 3rd molars);
I.N.R < 3.5
-
Exclusion Criteria:(Cirrhosis patients)
- Patient having systemic disorders other than hepatic disease(e.g. HIV, osteoporosis,diabetes,cardiovascular disease)
- Pregnancy
- Use of systemic and topical antibiotic treatment within 3 months prior to the start of the study.
The eligibility criteria of the control group were the same for the cirrhosis group, except for the presence of liver disease. Cirrhosis patients were matched with controls according to sex, age (± 3 years old) and current smoking status and alcohol satus (yes/no).
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Patients with liver cirrhosis
prevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis and change in MELD(model for end stage liver disease) will be checked after treatment.
|
Nonsurgical root canal treatment will be given
|
Active Comparator: Normal healthy patients
prevalence of apical periodontitis will be checked and non-surgical root canal treatment will be given to the patients with apical periodontitis
|
Nonsurgical root canal treatment will be given
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence of apical periodontitis in patients with cirrhosis and healthy patients.
Time Frame: Baseline to 12 months
|
periapical index score will be assigned to intraoral periapical radiograph of teeth showing periapical radiolucency in orthopantomogram of each patient .PAI score 3,4,5 will be diagnosed with apical periodontitis . Score Description
|
Baseline to 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
association of prevalence of marginal and apical periodontitis with mortality measured by MELD score in cirrhosis patients
Time Frame: Baseline to 12 months
|
Model for end stage liver disease score of all cirrhotic patients will be calculated using serum bilirubin, serum creatinine, and International Normalized Ratio (INR) by the formula 9.57 × loge (creatinine) + 3.78 × loge (total bilirubin) + 11.2 × loge (INR) + 6.43.
|
Baseline to 12 months
|
Clinical and radiographic success
Time Frame: Baseline to 12 months
|
Clinical success will be assessed by absence of clinical signs and symptoms and radiographically PAI score 1 ,2 will be considered as healed.
|
Baseline to 12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- swatiendo18787
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Cirrhosis
-
Postgraduate Institute of Medical Education and...Society for the Study of Liver Diseases, Chandigarh ( India )UnknownDecompensated Cirrhosis of LiverIndia
-
The Second Affiliated Hospital of Chongqing Medical...RecruitingFibrosis, Liver | Cirrhosis, LiverChina
-
SUUMC Central Military Hospital Dr Carol DavilaRecruiting
-
The Cleveland ClinicRecruiting
-
The Cleveland ClinicRecruitingCirrhosis, LiverUnited States
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedCirrhosis, LiverUnited States
-
Beth Israel Deaconess Medical CenterAmerican Association for the Study of Liver Diseases FoundationCompleted
-
Asian Institute of Gastroenterology, IndiaCompletedCirrhosis, LiverIndia
-
Sherief Abd-ElsalamUnknown
Clinical Trials on Nonsurgical root canal treatment
-
Postgraduate Institute of Dental Sciences RohtakActive, not recruiting
-
Postgraduate Institute of Dental Sciences RohtakCompletedPeriapical LesionsIndia
-
Postgraduate Institute of Dental Sciences RohtakActive, not recruiting
-
University of SienaCompleted
-
Malmö UniversityKronoberg County Council; County Council of Halland, Sweden; Norrbottens County... and other collaboratorsRecruitingPain | Apical Periodontitis | Tooth Loss | Dental Pulp NecrosisSweden
-
Fatima Memorial HospitalCompleted
-
King's College LondonCompletedDental Pulp DiseasesUnited Kingdom
-
University of EdinburghNHS LothianCompleted
-
Universitat Internacional de CatalunyaRecruitingIrreversible Pulpitis | Pulp NecrosesSpain
-
Cairo UniversityUnknown